WallStreetZenWallStreetZen

NASDAQ: QNCX
Quince Therapeutics Inc Stock

$0.75+0.00 (+0%)
Updated Jul 19, 2024
QNCX Price
$0.75
Fair Value Price
$0.19
Market Cap
$32.41M
52 Week Low
$0.63
52 Week High
$1.49
P/E
-0.99x
P/B
0.44x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$30.28M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
1.15
Operating Cash Flow
-$23M
Beta
1.06
Next Earnings
Aug 1, 2024
Ex-Dividend
N/A
Next Dividend
N/A

QNCX Overview

Quince Therapeutics, Inc., a biopharmaceutical company, focuses on advancing precision therapeutics for debilitating and rare diseases. The company has discovered a broad bone-targeting drug platform to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease. Its lead compound is NOV004, an anabolic peptide engineered to precisely target and concentrate at the bone fracture site The company was formerly known as Cortexyme, Inc. and changed its name to Quince Therapeutics, Inc. in August 2022. Quince Therapeutics, Inc. was incorporated in 2012 and is headquartered in South San Francisco, California.

Zen Score

Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how QNCX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

QNCX ($0.75) is overvalued by 302.53% relative to our estimate of its Fair Value price of $0.19 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
QNCX ($0.75) is not significantly undervalued (302.53%) relative to our estimate of its Fair Value price of $0.19 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
QNCX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more QNCX due diligence checks available for Premium users.

Be the first to know about important QNCX news, forecast changes, insider trades & much more!

Valuation

QNCX fair value

Fair Value of QNCX stock based on Discounted Cash Flow (DCF)
Price
$0.75
Fair Value
$0.19
Overvalued by
302.53%
QNCX ($0.75) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
QNCX ($0.75) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
QNCX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

QNCX price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.99x
Industry
-18.27x
Market
29.62x

QNCX price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.44x
Industry
6.22x
QNCX is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

QNCX's financial health

Profit margin

Revenue
$0.0
Net Income
-$11.1M
Profit Margin
0%
QNCX's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$159.3M
Liabilities
$85.1M
Debt to equity
1.15
QNCX's short-term assets ($70.44M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
QNCX's long-term liabilities ($75.28M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
QNCX's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
QNCX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$8.4M
Investing
$8.9M
Financing
$190.0k
QNCX's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

QNCX vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
QNCX$32.41M0.00%-0.99x0.44x
ICCC$32.50M-0.95%-8.16x1.32x
IMRX$32.92M-2.63%-0.59x0.42x
VYNE$30.95M-0.93%-1.76x0.37x
EQ$30.67M-4.40%-2.49x1.45x

Quince Therapeutics Stock FAQ

What is Quince Therapeutics's quote symbol?

(NASDAQ: QNCX) Quince Therapeutics trades on the NASDAQ under the ticker symbol QNCX. Quince Therapeutics stock quotes can also be displayed as NASDAQ: QNCX.

If you're new to stock investing, here's how to buy Quince Therapeutics stock.

What is the 52 week high and low for Quince Therapeutics (NASDAQ: QNCX)?

(NASDAQ: QNCX) Quince Therapeutics's 52-week high was $1.49, and its 52-week low was $0.63. It is currently -49.66% from its 52-week high and 18.48% from its 52-week low.

How much is Quince Therapeutics stock worth today?

(NASDAQ: QNCX) Quince Therapeutics currently has 43,215,233 outstanding shares. With Quince Therapeutics stock trading at $0.75 per share, the total value of Quince Therapeutics stock (market capitalization) is $32.41M.

Quince Therapeutics stock was originally listed at a price of $32.89 in May 9, 2019. If you had invested in Quince Therapeutics stock at $32.89, your return over the last 5 years would have been -97.72%, for an annualized return of -53.05% (not including any dividends or dividend reinvestments).

How much is Quince Therapeutics's stock price per share?

(NASDAQ: QNCX) Quince Therapeutics stock price per share is $0.75 today (as of Jul 19, 2024).

What is Quince Therapeutics's Market Cap?

(NASDAQ: QNCX) Quince Therapeutics's market cap is $32.41M, as of Jul 22, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Quince Therapeutics's market cap is calculated by multiplying QNCX's current stock price of $0.75 by QNCX's total outstanding shares of 43,215,233.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.